alpha-aminopyridine has been researched along with apr-246 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Chen, Y; Deng, WG; Guo, W; Jiang, W; Li, L; Li, Y; Li, Z; Liao, Y; Xu, X; Yu, W; Zhang, Z; Zhao, X; Zou, K; Zou, L | 1 |
1 other study(ies) available for alpha-aminopyridine and apr-246
| Article | Year |
|---|---|
Synergistic Antitumor Effect of BKM120 with Prima-1Met Via Inhibiting PI3K/AKT/mTOR and CPSF4/hTERT Signaling and Reactivating Mutant P53.
Topics: Aminopyridines; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cleavage And Polyadenylation Specificity Factor; Cyclin-Dependent Kinase Inhibitor p21; Down-Regulation; Female; Humans; Mice; Mice, Nude; Morpholines; Proto-Oncogene Proteins c-akt; Quinuclidines; Signal Transduction; Thyroid Neoplasms; TOR Serine-Threonine Kinases; Tumor Suppressor Protein p53; Up-Regulation | 2018 |